Endometritis is a common condition affecting 10-15% of cows in the days or weeks after calving, although some 80-90% of cows have some degree of bacterial contamination post-calving.1,2 Both clinical endometritis and sub-clinical disease can result in lower fertility and reduced milk yield, as well as systemic effects and increased culling rates, with considerable economic impact for farmers.
BIMACURE is supplied in packs of ten sets each of cefapirin syringes, administration catheters and gloves for on-farm convenience. To ensure efficient administration, the catheter and syringe connection have been specially designed to avoid ‘pop offs’ at critical moments.
Rachel Mallet, Technical & Commercial Veterinarian for Bimeda® UK says she is delighted Bimeda are launching this latest product innovation for cattle, “BIMACURE is a great addition to our growing large animal portfolio of veterinary pharmaceuticals. Effectively managing the post-partum period is key to ensuring the long-term viability and productivity of the herd and we are very pleased to be able to offer vets and producers a solution and format that is designed to meet their needs. Veterinarian feedback about the product from other markets has been extremely positive. This launch reinforces our commitment to deliver high-quality, responsible, and effective animal health solutions.”
Veterinary surgeons who need to find out more can contact Bimeda® on 01248 725400 or uksales@bimeda.com. BIMACURE is now available to order from veterinary wholesalers.
Use of BIMACURE should follow the Summary of Product Characteristics (SPC) found on the VMD or NOAH Compendium websites.
About Bimeda®
Bimeda® is a global leader in animal health, supplying high-quality veterinary pharmaceuticals and animal health products in more than 80 countries. Its mission is to support veterinarians and producers with effective, science-based solutions that promote animal well-being and sustainable production. https://www.bimeda.co.uk/ https://www.linkedin.com/company/bimeda-ireland/ https://www.facebook.com/Bimeda.UK.Ireland/
Bimacure 500mg Intrauterine Suspension for Cattle is a POM-V medicine containing 500mg Cefapirin per syringe. It is licenced for the treatment of subacute and chronic endometritis in cows (at least 14 days after parturition) caused by bacteria susceptible to cefapirin. For further information see the SPC
available on the VMD website. Prescription decisions are for the person issuing the prescription alone. Date prepared: January 2026. Bimeda® can be contacted on +44 (0)1248 725 400 or uksales@bimeda.com. Use Medicines Responsibly. Noah.co.uk/responsible.
References
1. https://www.nadis.org.uk/disease-a-z...20discharge%20 from%20the%20vulva 2. https://projectblue.blob.core.window...191217_WEB.pdf
Attached Files